REPL Replimune Group Inc
815
$5.71
$0.22
(3.71%)
| Watchers | 815 |
| 52-Wk Low | $5.46 |
| 52-Wk High | $24.81 |
| Market Cap | $364.19M |
| Volume | 176,347.00 |
| 52-Wk High | $24.81 |
| 52-Wk Low | $5.46 |
Replimune Group presents interim results from ARTACUS trial of RP1 monotherapyThe Fly • about 2 months ago
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Share to Feed
RP1 monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent and complete response rate of nearly 22 percent in evaluable patientsSAN DIEGO, April 07, 2024...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
WOBURN, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of a novel class of oncolytic...
This price move could indicate a change in the trend, and may be a buy signal for investors...
Replimune Group announces CEO transition...
Philip Astley-Sparke to transition from current role of CEO to Executive Chairman Planned leadership changes position the Company for commercialization Preparations on track to submit RP1...
Over the last three days, A.I.dvisor has detected that REPL's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...
This price move could be a signal that REPL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options...
Over the last three days, A.I.dvisor has detected that REPL's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...